Kadcyla (trastuzumab emtansine) powder for concentrate for solution for infusion — original (Roche, Switzerland) Targeted cancer therapy. Delivery of medications f All Europe and elsewhere within 4-5 days. Storage conditions are met. Payment upon receipt. Order by calling +380996042415, Viber, WhatsApp.

Indications

• Kadcyla ® is used in patients with HER2-positive, unresectable, locally or metastatic breast cancer as monotherapy following previous chemotherapy that included trastuzumab and a taxane drug (alone or in combination), or in cases of disease recurrence during or within 6 months of completion of adjuvant therapy that included trastuzumab and a taxane drug (alone or in combination).